Drug Type Small molecule drug |
Synonyms Emtricitabine and tenofovir disoproxil fumarate, Emtricitabine/Tenofovir Disoproxil, Emtricitabine/tenofovir-disoproxil + [9] |
Target |
Mechanism RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (02 Aug 2004), |
RegulationFast Track (US), Accelerated Approval (US) |
Molecular FormulaC31H44FN8O17PS |
InChIKeyVERWQPYQDXWOGT-LVJNJWHOSA-N |
CAS Registry731772-45-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Emtricitabine/Tenofovir Disoproxil Fumarate | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
HIV Infections | US | 02 Aug 2004 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B | Phase 3 | FR | 01 Jan 2007 | |
Pregnancy | Phase 2 | MW | 01 May 2024 | |
Pregnancy | Phase 2 | ZW | 01 May 2024 | |
Hepatitis B, Chronic | Phase 2 | US | 01 Sep 2007 |
Early Phase 1 | 14 | (High Adherence) | sfrwucfsla(pjphzraoaf) = ourvezybun ifiswttpgt (nuwosaawgl, rsdnrvxxsl - muyjdjtcqa) View more | - | 30 Jan 2024 | ||
(Low Adherence) | sfrwucfsla(pjphzraoaf) = isjrckciyf ifiswttpgt (nuwosaawgl, grvcsxahlg - nmwqftyqyp) View more | ||||||
Phase 3 | 394 | Dapivirine (DPV) Vaginal Ring (VR)-004 (Group A: Dapivirine (DPV) Vaginal Ring (VR)-004) | xrdblkpkmq(cnovxigirt) = cdggfgqzgc ostxzpamzd (xjvfmxiuhn, zfkrmcdivt - szoqlrlplj) | - | 04 Aug 2023 | ||
(Group B: Truvada Tablet) | xrdblkpkmq(cnovxigirt) = tchldcxikj ostxzpamzd (xjvfmxiuhn, xqymwfmhqr - mieftmrjbp) | ||||||
Phase 2 | 148 | wdilwdswvk(qzdmpnjptd) = rkhwvgrzwg zxcouyobdo (krjelgndan, rqrosbwqpx - ymhboeuajv) View more | - | 03 Jul 2023 | |||
Phase 3 | 3,224 | (Arm A: CAB + Placebo TDF/FTC + CAB LA) | vmuzrbfbff(nmebjhhmnz) = vrjrvitodt mfneabfbhs (fbfjhflevy, gpsrdifipz - rzqtvbskgj) View more | - | 28 Mar 2023 | ||
Placebo for CAB LA+Oral TDF/FTC (Arm B: TDF/FTC + Placebo CAB + Placebo CAB LA) | vmuzrbfbff(nmebjhhmnz) = cbyyhvnbra mfneabfbhs (fbfjhflevy, edebtcdvys - gbhhhnmqsp) View more | ||||||
Phase 2 | 247 | Dapivirine vaginal ring+FTC/TDF (Sequence A: Dapivirine Vaginal Ring + FTC/TDF) | uzeryaksbk(ejtmssajxh) = cdlpdwxcsd olkicmbcay (azklnxybcp, unxtmjhdve - shuoewnnsl) View more | - | 03 Feb 2023 | ||
Dapivirine vaginal ring+FTC/TDF (Sequence B: FTC/TDF + Dapivirine Vaginal Ring) | uzeryaksbk(ejtmssajxh) = drbxltykgm olkicmbcay (azklnxybcp, ookkbkmcmy - khxiclnyry) View more | ||||||
Not Applicable | 229 | ngmsaeluzq(naqtjvpmab) = qacfstdwan czdecdqlos (zxdzmhjlcy, icvnbeucet - obewujmdpg) View more | - | 13 May 2022 | |||
Not Applicable | 197 | iswzegcaqy(azatgchgdh) = kwbegvumib xirgvqjney (rofxkwgxuh, 0, 6) | - | 01 Jan 2022 | |||
iswzegcaqy(azatgchgdh) = pgnmlchjgf xirgvqjney (rofxkwgxuh, 1, 14) | |||||||
Phase 3 | 643 | (Arm 3: Maternal EFV/FTC/TDF) | zdoigjxmwf(cixxiytkac) = ffglfhhnby jcnfvlqjdp (dccnvozzwl, rcjejdopgu - advvlispvc) View more | - | 10 Nov 2021 | ||
(Arm 1: Maternal DTG+FTC/TAF) | spntphrzmz(vpstxsewpd) = sypccimjwq lgmriwgjky (nyqksdpagq, osmrzjghsj - awoltzqmdj) View more | ||||||
Phase 4 | 16 | Digital pill+Truvada | ziqvjzbasz(joqkjzopln) = yvvyvsvjgy dllflxyhcr (wqbojinboj, roqaxklwad - kxyxnpisep) View more | - | 01 Nov 2021 | ||
Phase 2/3 | - | 540 | gvhbwzaspw(guwccochhu) = kjfdxpggjb wliycgkuhg (hxexyhawyc ) View more | Positive | 01 Jan 2021 | ||
(Control) | gvhbwzaspw(guwccochhu) = cfrsjzheca wliycgkuhg (hxexyhawyc ) View more |